financetom
Market
financetom
/
Market
/
Opening Bell: Sensex, Nifty open higher amid positive global cues; banks, metals, auto lead gains
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Opening Bell: Sensex, Nifty open higher amid positive global cues; banks, metals, auto lead gains
Jul 12, 2021 12:44 AM

Indian equity benchmark indices opened higher on Monday led by across-the-board gains amid positive momentum in Asian peers on strong global cues.

Share Market Live

NSE

At 9:15 am, the Sensex opened 0.47 percent, or 248.14 points, higher at 52,634.33, while the Nifty50 index opened at 15,766.80, up 77.00 points, or 0.49 percent.

Broader markets supported the uptrend, with Nifty Smallcap100 and Nifty Midcap100 indices up 1.08 percent and 0.66 percent respectively.

All the sectoral indices are trading in the green with the Nifty Bank, Nifty Metal, Nifty Auto, and Nifty IT rallying the most in the early morning session.

ICICI Bank, Maruti Suzuki, SBI, IndusInd Bank, and Tata Motors were the top Nifty50 gainers, while Bajaj Finserv, HDFC Bank, and Hindustan Unilever were the only ones to trade in the red.

Shares of Equitas Small Finance Bank rallied over 14 percent, while that of Equitas Holdings jumped 20 percent after it got the Reserve Bank of India’s permission to apply for the scheme of amalgamation.

Globally, Asian shares were enjoying a relief rally on Monday as record highs on Wall Street and policy easing in China helped calm some of the recent jitters on global growth, though plenty of potential pitfalls lay ahead this week, said a Reuters report.

MSCI’s broadest index of Asia-Pacific shares outside Japan gained 0.9 percent, while Japan’s Nikkei bounced 2.3 percent.

Meanwhile, oil prices steadied after ending a volatile week with a bounce as US inventories tightened. Dealers are still uncertain about the outlook for supplies after OPEC talks on restrictions broke down.

Brent was last down 4 cents at $75.51 a barrel, while US crude stood unchanged at $74.56.

In the commodity market, gold prices edged lower but were still hovering above the key levels of $1,800 an ounce.

Catch all the latest updates from the stock market here.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US STOCKS-Wall Street shakes off tariff concerns, Nvidia leaps to $4 trillion
US STOCKS-Wall Street shakes off tariff concerns, Nvidia leaps to $4 trillion
Jul 9, 2025
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * Indexes up: Dow 0.06%, S&P 500 0.24%, Nasdaq 0.55% * Nvidia ( NVDA ) first company to hit $4 trillion market value * AES ( AES ) jumps on report of sale efforts * UnitedHealth ( UNH )...
Exchange-Traded Funds, US Equities Rise After Midday
Exchange-Traded Funds, US Equities Rise After Midday
Jul 9, 2025
01:09 PM EDT, 07/09/2025 (MT Newswires) -- Broad Market Indicators Broad-market exchange-traded funds IWM and IVV rose. Actively traded Invesco QQQ Trust (QQQ) was up 0.4%. US equity indexes rose with the Nasdaq Composite climbing to a record as Nvidia ( NVDA ) became the first company ever to surpass $4 trillion in market capitalization. Energy iShares US Energy ETF...
Sector Update: Tech
Sector Update: Tech
Jul 9, 2025
01:15 PM EDT, 07/09/2025 (MT Newswires) -- Tech stocks were higher Wednesday afternoon, with the Technology Select Sector SPDR Fund (XLK) and the SPDR S&P Semiconductor ETF (XSD) each adding 0.2%. The Philadelphia Semiconductor index rose 0.4%. In corporate news, Microsoft's ( MSFT ) AI business potential is being underestimated by the market, according to Oppenheimer, which believes the tech...
Update: Rhythm Pharmaceuticals Shares Surge After Bivamelagon Reduces BMI in Hypothalamic Obesity Trial
Update: Rhythm Pharmaceuticals Shares Surge After Bivamelagon Reduces BMI in Hypothalamic Obesity Trial
Jul 9, 2025
11:42 AM EDT, 07/09/2025 (MT Newswires) -- (Updates with the latest stock move in the headline and the first paragraph.) Rhythm Pharmaceuticals ( RYTM ) shares jumped nearly 33% in recent Wednesday trading after the company said bivamelagon achieved body mass index reductions in patients in its phase 2 acquired hypothalamic obesity trial. At 14 weeks of treatment, bivamelagon cut...
Copyright 2023-2026 - www.financetom.com All Rights Reserved